| Zeit | Aktuelle Nachrichten Sprache: 
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.08. | Klaria Pharma Holding AB: Klaria Interim Report Q2 2025 | 179 | GlobeNewswire (Europe) | Klaria interim report
1 April-30 June 2025
Summary of the interim reportSecond quarter of 2025 The group in total 
- Net sales 0.0 MSEK (0.0 MSEK) 
- Other income 0.0 MSEK (0.0 MSEK) 
- R&D expenses... ► Artikel lesen | |
| 03.07. | KLARIA PHARMA HOLDING AB: Klaria stengthens patent portfolio of sumatriptan alginate film with new filing | 5 | Cision News | ||
| 18.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 18.06.2025 | 539 | Xetra Newsboard | Das Instrument FCC ES0122060314 FOMENT.CON.CONTR.INH.EO 1 EQUITY wird ex Kapitalmassnahme gehandelt am 18.06.2025 The instrument FCC ES0122060314 FOMENT.CON.CONTR.INH.EO 1 EQUITY is traded ex capital... ► Artikel lesen | |
| KLARIA PHARMA Aktie jetzt für 0€ handeln | |||||
| 21.05. | KLARIA PHARMA HOLDING AB: Klaria Interim Report | 5 | Cision News | ||
| 28.02. | Klaria Pharma Holding AB: Klaria Year-End Report 2024 | 218 | GlobeNewswire (Europe) | Klaria year-end report 1 Jan - 31 Dec 2024
Summary of the reportFourth quarter of 2024
The group in total 
- Net sales 1.1 MSEK (1.3 MSEK) 
- Other income 0.0 MSEK (0.3 MSEK) 
- R&D expenses for... ► Artikel lesen | |
| 10.01. | Klaria Pharma Holding AB: Klaria signs license agreement for Sumatriptan Alginate film in Europe with CNX Therapeutics | 356 | GlobeNewswire (Europe) | Klaria Pharma Holding AB (publ) ("Klaria" or the "Company") announces that the Company has signed a license agreement for Sumatriptan Alginate Film (the "Product"), a pharmaceutical product based on... ► Artikel lesen | |
| 21.11.24 | Klaria Pharma Holding AB: Klaria Interim Report Q3 2024 | 160 | GlobeNewswire (Europe) | Klaria Interim Report Q3 2024
1 July - 30 September 2024
Third quarter of 2024 
The group in total 
- Net sales 0.0 MSEK (0.6 MSEK) 
- Other income 0.0 MSEK (0.0 MSEK) 
- R&D expenses for the... ► Artikel lesen | 
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB | 40,265 | +3,05 % | EQS-News: Evotec SE: Evotec gibt Fortschritt in präklinischer Neurologie-Partnerschaft mit Bristol Myers Squibb bekannt | EQS-News: Evotec SE
 / Schlagwort(e): Sonstiges
Evotec gibt Fortschritt in präklinischer Neurologie-Partnerschaft mit Bristol Myers Squibb bekannt 
27.10.2025 / 07:30 CET/CEST
Für... ► Artikel lesen | |
| DERMAPHARM | 34,000 | +0,30 % | Kurs der Dermapharm-Aktie verharrt auf Vortags-Niveau (31,85 €) | Der Kurs der der Dermapharm-Aktie kommt kaum von der Stelle. Der jüngste Kurs betrug 31,85 Euro. Ein geringes Minus von 0,78 Prozent zeigt die Kurstafel für der Anteilsschein von Dermapharm an. Die... ► Artikel lesen | |
| SYNBIOTIC | 2,590 | -1,89 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte | EQS-News: SYNBIOTIC SE
 / Schlagwort(e): Stellungnahme
SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte... ► Artikel lesen | |
| INCYTE | 81,96 | +2,42 % | Incyte to Present at Upcoming Investor Conferences | Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November: 
  		
Guggenheim Annual Healthcare Innovation Conference on Monday, November... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
| GREEN THUMB INDUSTRIES | 5,870 | -0,76 % | Green Thumb Industries Inc: Green Thumb Industries to release Q3 results Nov. 5 | ||
| INDIVA | 0,016 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.06.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.06.2025.ISIN NameCA45580J1012	INDIVA... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 0,995 | 0,00 % | Happy Belly Food Group Inc.: Happy Belly Food Group's Yolks Breakfast Signs Franchise Agreement for the City of Edmonton, Alberta | Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands... ► Artikel lesen | |
| CSPC PHARMA | 0,870 | +7,81 % | CSPC PHARMA (01093): UNAUDITED FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2025 | ||
| TONIX PHARMACEUTICALS | 16,300 | +3,16 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Presented Data on Tonmya (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence | ||
| PSYCHED WELLNESS | 0,009 | +41,67 % | Psyched Wellness Ltd.: Psyched Wellness Provides Comprehensive Investor Update | Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production... ► Artikel lesen | |
| OPKO HEALTH | 1,246 | -0,61 % | OPKO Health, Inc.: OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results | MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 1,630 | -3,09 % | SELLAS Life Sciences raises $31 million through warrant exercise | ||
| COSMO PHARMACEUTICALS | 72,50 | -0,68 % | Cosmo Pharmaceuticals N.V.: Cosmo Pharmaceuticals Receives Regulatory Approval by the European Commission for Winlevi(R) in the EU, Following on the Positive CHMP Opinion | Dublin, Ireland--(Newsfile Corp. - October 21, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that the European Commission... ► Artikel lesen | |
| SWEET EARTH | 0,324 | -100,00 % | CSE Bulletin: 2025 - 0621 - Halted for Fundamental Change - Sweet Earth Holdings Corporation (SE) | Toronto, Ontario--(Newsfile Corp. - Le 19 juin/June 2025) - Trading in the shares of Sweet Earth Holdings Corporation (SE) will remain halted pending receipt and review of acceptable documentation... ► Artikel lesen |